SADDLE RIVER, N.J.--(BUSINESS WIRE)--PDI, Inc. (NASDAQ:PDII), a provider of commercialization services to the biopharmaceutical industry, today announced that it has signed an agreement with a major pharmaceutical company for a new contract sales engagement. The initiative will utilize PDI’s exclusive Select Access Team to reach pediatricians. The fee-for-service contract, commencing January 2008, is expected to generate approximately $7.5 million in revenue for PDI over its 12-month term.
